Gary M. Owens - 19 Mar 2025 Form 4 Insider Report for MESA LABORATORIES INC /CO/ (MLAB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Mar 2025, 13:38:04 UTC
Prior SEC filing
29 Oct 2024
Next SEC filing
11 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John Sakys under Power of Attorney by Gary Owens

Key filing fact

Gary M. Owens filed Form 4 for MESA LABORATORIES INC /CO/ (MLAB) on 24 Mar 2025.

Key facts

  • This page summarizes Gary M. Owens's Form 4 filing for MESA LABORATORIES INC /CO/ (MLAB).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 Mar 2025, 13:38.

Change

  • Previous filing in this sequence was filed on 29 Oct 2024.
  • Current net transaction value: -$19,530.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MLAB transaction

Common Stock

Options Exercise

Transaction value
$2,582,580
Shares
+21,000
Change %
+48%
Price
$122.98
Shares after
64,337
Date
19 Mar 2025
Ownership
Direct
MLAB transaction

Common Stock

Sale

Transaction value
$2,602,110
Shares
-21,000
Change %
-33%
Price
$123.91
Shares after
43,337
Date
19 Mar 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MLAB transaction Derivative

Non qualified Stock Option

Exercise of in-the-money or at-the-money derivative security

Transaction value
$0
Shares
-21,000
Change %
-22%
Price
$0.000000
Shares after
73,769
Date
19 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,000
Exercise price
$122.98
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

1/7 exercisable on each anniversary date of the 03/20/2017 grant date

Footnote F2

Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on September 12, 2024

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .